Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$770K Sell
17,160
-8,889
-34% -$337K 0.36% 125
2020
Q1
$853K Sell
26,049
-3,704
-12% -$188K 0.39% 81
2019
Q4
$1.91M Sell
29,753
-21,178
-42% -$1.39M 0.53% 23
2019
Q3
$3.31M Sell
50,931
-17,216
-25% -$1M 0.61% 10
2019
Q2
$3.51M Buy
68,147
+9,658
+17% +$477K 0.62% 11
2019
Q1
$2.81M Buy
+58,489
New +$2.63M 0.49% 76
2018
Q2
Sell
-29,382
Closed -$1.38M 364
2018
Q1
$1.38M Sell
29,382
-18,345
-38% -$930K 0.34% 179
2017
Q4
$2.34M Buy
47,727
+62
+0.1% +$2.77K 0.58% 53
2017
Q3
$2.21M Buy
+47,665
New +$2.08M 0.42% 97
2016
Q1
Sell
-3,251
Closed -$57K 133
2015
Q4
$57K Buy
+3,251
New +$57.8K 0.47% 65

Other funds holding MTZ

361 Capital's MTZ Position: Q2 2020 in Review

361 Capital reduced its MasTec (MTZ) stake by 34% in Q2 2020, selling an estimated $337K and leaving 17,160 shares worth $770K. The position accounts for 0.36% of the portfolio, ranked #125.

361 Capital first reported a position in MTZ in Q4 2015 and has held it in 10 quarters since. The position peaked at $3.51M in Q2 2019. 321 funds tracked by Wall St. Rank hold MTZ as of Q2 2020.

  • 361 Capital held 17,160 shares of MasTec worth $770K as of Q2 2020.
  • 361 Capital sold 8,889 MasTec shares in Q2 2020, an estimated $337K.
  • MasTec made up 0.36% of 361 Capital's portfolio in Q2 2020, its #125 holding.
  • 361 Capital first reported a position in MasTec in Q4 2015 and has held it in 10 quarters since.
  • 361 Capital's MasTec position peaked at $3.51M in Q2 2019.
  • 321 funds tracked by Wall St. Rank held MasTec as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.